Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic potential of small interfering RNA for central nervous system diseases.

Archives of neurology - 1 Dec 2005

Lovett-Racke Amy E, Cravens Petra D, Gocke Anne R, Racke Michael K, Stüve Olaf

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Brain Neoplasms
Share to Central Nervous System Diseases
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Sclerosis

Share to RNA Interference

Share to RNA, Small Interfering

Share to Spinocerebellar Ataxias

Source

Identifiers

PMID: 16344338
DOI: 10.1001/archneur.62.12.1810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic potential of small interfering RNA for central nervous system diseases.PMID 16344338Read ↗

RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseasesSemantic proximity Read ↗

RNA therapeutics for neurological diseasesSemantic proximity Read ↗

Antisense oligonucleotides: the next frontier for treatment of neurological disordersSemantic proximity Read ↗

The expanding application of antisense oligonucleotides to neurodegenerative diseasesSemantic proximity Read ↗

Antisense drugs for rare and ultra-rare genetic neurological diseasesSemantic proximity Read ↗

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseasesSemantic proximity Read ↗

Antisense oligonucleotides: A promising advancement in neurodegenerative disease treatmentSemantic proximity Read ↗

Antisense Drugs Make Sense for Neurological DiseasesSemantic proximity Read ↗

Small interfering RNA.Semantic proximity Read ↗

RNA-targeted drugs for neuromuscular diseasesSemantic proximity Read ↗

Neurodegenerative Disorders Treatment: The MicroRNA RoleSemantic proximity Read ↗

Ribonucleic acid interference: the relevance of molecular targeting and therapeutics to neurosurgical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.